Abstract
Liver biopsy is the gold standard in the evaluation of hepatic disease. It is extremely effective in assessing the histologic degree of fibrosis. Traditional sampling methods can be quite invasive and pose serious risks to the patient. Transjugular, percutaneous and other biopsy methods carry the risk of bleeding, pain and damage to the surrounding organs [1, 2]. The emergence of EUS-guided liver biopsy (EUS-LB) allows the endoscopist to offer a sampling method with decreased risk of adverse events and robust advantages such as decreased pain, increased safety from continuous ultrasound guidance, easily acquisition of multiple samples with a widened view of the organ in one session, and performance in the outpatient setting [2, 3]. EUS-LB accurately evaluates fibrosis in patients with fatty liver disease [4]. Several studies showcase diagnostic yields ranging from 91–100% [5–7].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Shiha GIA, Helmy A. Asian-Pacific Association for the Study of the liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update. Hepatol Int. 2017;11:1–30.
Johnson KD, Laoveeravat P, Yee EU, Perisetti A, Thandassery RB, Tharian B. Endoscopic ultrasound guided liver biopsy: recent evidence. World Journal of Gastrointestinal Endoscopy. 2020;12(3):83–97.
Diehl DL. Endoscopic ultrasound-guided liver biopsy. Interventional Endoscopic Ultrasound. June 2018:83–94.
Saab SPJ, Jimenez MA, et al. Endoscopic ultrasound liver biopsies accurately predict the presence of fibrosis in patients with fatty liver. Clin Gastroenterol Hepatol. 2017;15:1477–8.
Shah N, Baron T. Taking a poke at the liver: which way is best? Endoscopy International Open. 2019;07(01)
Campos S, Poley J-W, Driel LV, Bruno MJ. The role of EUS in diagnosis and treatment of liver disorders. Endoscopy International Open. 2019;07(10)
Saraireh HA, Bilal M, Singh S. Role of endoscopic ultrasound in liver disease: where do we stand in 2017? World J Hepatol. 2017;9(24):1013.
Conflicts of Interest
Ameya Deshmukh: None. Ahmed Mohammed Elmeligui: None. Javier Tejedor-Tejada: None. Jose Nieto: Consultant for Boston Scientific.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
1 Electronic Supplementary Material
EUS-guided liver biopsy for NAFLD (MP4 18,176 kb)
Funding Support
Non-declared.
Rights and permissions
Copyright information
© 2022 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Deshmukh, A., Elmeligui, A.M., Tejedor-Tejada, J., Nieto, J. (2022). EUS-Guided Liver Biopsy in Nonalcoholic Fatty Liver Disease. In: Teoh, A.Y., Giovaninni, M., Khashab, M.A., Itoi, T. (eds) Atlas of Interventional EUS. Springer, Singapore. https://doi.org/10.1007/978-981-16-9340-3_51
Download citation
DOI: https://doi.org/10.1007/978-981-16-9340-3_51
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-9339-7
Online ISBN: 978-981-16-9340-3
eBook Packages: MedicineMedicine (R0)